carcinolipin

05/01/1996 - "Follow-up of patients with all these types of cancer revealed that changes in their clinical condition are accompanied with significant alterations in the cholesteryl 14-methylhexadecanoate level. "
05/01/1996 - "Concentration of cholesteryl 14-methylhexadecanoate was determined by high-performance liquid chromatography in serum of 123 healthy individuals, 83 of patients with other diseases than cancer, and of 394 patients with cancer. "
10/14/1994 - "The quantification of cholesteryl 14-methylhexadecanoate is precise and highly reproducible and the analysis may be completed within 35 min. The level of CMH in the blood of cancer patients appears to be a useful marker of malignant tumors."
01/01/1985 - "The turn-over of the cholesteryl 14-methylhexadecanoate in the liver was significantly changed at the late stages of the tumor growth. "
01/01/1975 - "The role of cholesteryl 14-methylhexadecanoate in gene expression and its significance for cancer."

01/01/1979 - "Biosynthesis of cholesteryl 14-methylhexadecanoate in the liver of rats bearing transplantable tumors and during chemical carcinogenesis."

01/01/1979 - "Biosynthesis of cholesteryl 14-methylhexadecanoate, cholesteryl palmitate and cholesteryl stearate was studied in the liver of rats bearing the Walker 256 carcinoma. "